Why the study?
Does tamoxifen increase the risk of thromboembolism in patients with a known predisposition to thrombosis?
Population
A 72-year-old woman with metastatic pleural effusion and bone disease from breast cancer, with a history of…
Design
Case_report
Follow-up
1 month
Authors
Loading...
May warrant caution with tamoxifen in thrombosis-prone patients; hypothesis-generating and requires confirmation in controlled studies.
Does tamoxifen increase the risk of thromboembolism in patients with a known predisposition to thrombosis?
This case report raises concerns about the safety of tamoxifen in patients with a known predisposition to thrombosis due to its potential paradoxical estrogenic effects.
Alex Hendrick (1980) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: